Tsutomu Hirano

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Topics

Psychometric Properties

Cardiovascular Disease

Top Venues

Journal of diabetes investigation

Diabetology international

International journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Tsutomu Hirano
No change in small low-density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial. Journal of diabetes investigation 14 (4) (2023)
Tsutomu Hirano, Toshiyuki Hayashi, Hiroe Sugita, Atsuko Tamasawa, Satoshi Goto, Masako Tomoyasu, Takeshi Yamamoto, Makoto Ohara, Michishige Terasaki, Hideki Kushima, Yasuki Ito, Sho-Ichi Yamagishi, Yusaku Mori
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy. Journal of diabetes investigation (2023)
Tsutomu Hirano
No change in small low-density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial. Journal of diabetes investigation 14 (4) (2023)
Tsutomu Hirano
No change in small low-density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial. Journal of diabetes investigation (2023)
Tsutomu Hirano
No change in small low-density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial. Journal of diabetes investigation 14 (4) (2023)
Tsutomu Hirano, Yasuki Ito
The influence of triglycerides on small dense low-density lipoprotein cholesterol levels is attenuated in low low-density lipoprotein-cholesterol range: Implications for the negative results of the PROMINENT trial. Journal of diabetes investigation (2023)
Tsutomu Hirano
Hypertriglyceridemia contributes significantly to high prevalence of small dense LDL-cholesterol in patients with type 2 diabetes, even when LDL-C targets are achieved. Diabetology international 14 (3) (2023)
Ema Aoki, Takeshi Hirashima, Yuko Kumamoto, Yuko Yamamoto, Natsuko Suzuki, Taito Oshima, Daizo Saito, Tsutomu Hirano
Clinical significance of skin autofluorescence for diabetic macroangiopathy and comparison with conventional markers of atherosclerosis: a cross-sectional and prospective study. Diabetology international 14 (2) (2022)
Ema Aoki, Takeshi Hirashima, Yuko Kumamoto, Yuko Yamamoto, Natsuko Suzuki, Taito Oshima, Daizo Saito, Tsutomu Hirano
Clinical significance of skin autofluorescence for diabetic macroangiopathy and comparison with conventional markers of atherosclerosis: a cross-sectional and prospective study. Diabetology international 14 (2) (2022)
Ema Aoki, Takeshi Hirashima, Yuko Kumamoto, Yuko Yamamoto, Natsuko Suzuki, Taito Oshima, Daizo Saito, Tsutomu Hirano
Clinical significance of skin autofluorescence for diabetic macroangiopathy and comparison with conventional markers of atherosclerosis: a cross-sectional and prospective study. Diabetology international 14 (2) (2022)
Ema Aoki, Takeshi Hirashima, Yuko Kumamoto, Yuko Yamamoto, Natsuko Suzuki, Taito Oshima, Daizo Saito, Tsutomu Hirano
Clinical significance of skin autofluorescence for diabetic macroangiopathy and comparison with conventional markers of atherosclerosis: a cross-sectional and prospective study. Diabetology international 14 (2) (2022)
Michishige Terasaki, Hironori Yashima, Tomomi Saito, Tomomi Saito, Yoshie Shiraga, Raichi Kawakami, Makoto Ohara, Tomoyasu Fukui, Tsutomu Hirano, Yuichiro Yamada, Yutaka Seino, Sho-Ichi Yamagishi
Glucose-Dependent Insulinotropic Polypeptide Suppresses Foam Cell Formation of Macrophages through Inhibition of the Cyclin-Dependent Kinase 5-CD36 Pathway. Biomedicines 9 (7) (2021)
Tsutomu Hirano, Noriyuki Satoh, Rieko Kodera, Takeshi Hirashima, Natsuko Suzuki, Ema Aoki, Taito Oshima, Mitsuru Hosoya, Masahiro Fujita, Toshiyuki Hayashi, Yasuki Ito
Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort. Journal of diabetes investigation (2021)
Taisuke Okano, Kengo Sato, Remina Shirai, Tomomi Seki, Koichiro Shibata, Tomoyuki Yamashita, Ayaka Koide, Hitomi Tezuka, Yusaku Mori, Tsutomu Hirano, Takuya Watanabe
β-Endorphin Mediates the Development and Instability of Atherosclerotic Plaques. International journal of endocrinology 2020 (2020)
Michishige Terasaki, Munenori Hiromura, Yusaku Mori, Kyoko Kohashi, Hideki Kushima, Masakazu Koshibu, Tomomi Saito, Hironori Yashima, Takuya Watanabe, Tsutomu Hirano
A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients. International journal of endocrinology 2018 (2018)
Michishige Terasaki, Munenori Hiromura, Yusaku Mori, Kyoko Kohashi, Hideki Kushima, Makoto Ohara, Takuya Watanabe, Olov Andersson, Tsutomu Hirano
Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice. International journal of endocrinology 2017 (2017)